1. Ostapenko V, Weber WP, Matrai Z, Hayoz S, Tausch C. Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101). Breast. 2021 Dec;60:98-110. doi: 10.1016/j.breast.2021.09.004. Epub 2021 Sep 8. PMID: 34555676; PMCID: PMC8463904.
2. Ostapenko V, Laurinavicius A. Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients. Front Oncol. 2021 Nov 11;11:774088. doi: 10.3389/fonc.2021.774088. PMID: 34858854; PMCID: PMC8631965.
3. Ostapenko V, Fitzal F, Bolliger M. Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study. Ann Surg Oncol. 2022 Feb;29(2):1061-1070. doi: 10.1245/s10434-021-10809-1. Epub 2021 Oct 13. PMID: 34647202; PMCID: PMC8724061.
4. Ostapenko V, Burneckis A, Ostapenko A, Skaisgirytė A, Ostapenko V. Malignant phyllodes tumor of the breast with metastases to the lungs: A case report and literature review. Radiol Case Rep. 2022 Aug 18;17(10):4006-4012. doi: 10.1016/j.radcr.2022.07.037. PMID: 36039084; PMCID: PMC9418210.
5. Ostapenko V, Sadzeviciene I, Snipaitiene K, Scesnaite-Jerdiakova A, Daniunaite K, Sabaliauskaite R, Laurinaviciene A, Drobniene M, Jarmalaite S. Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases. Int J Mol Sci. 2022 Dec 6;23(23):15429. doi: 10.3390/ijms232315429. PMID: 36499753; PMCID: PMC9741387.
6. Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S. The Impact of the COVID-19 Pandemic on Cancer Patient’s Management-Lithuanian Cancer Center Experience. Healthcare (Basel). 2021 Nov 9;9(11):1522. doi: 10.3390/healthcare9111522. PMID: 34828568; PMCID: PMC8623620.
7. Ostapenko V, Pieńkowski T, Podolski P, Vogel T, Yin J, Özmen V, Schneebaum S, Mathelin C. Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) Survey. Eur J Breast Health. 2023 Jul 3;19(3):201-209. doi: 10.4274/ejbh.galenos.2023.2023-5-1. PMID: 37415654; PMCID: PMC10320638.
8. Ostapenko V, Özbaş S, Özmen V, Pagani O, Pieńkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M. Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey. Eur J Breast Health. 2021 Mar 31;17(2):188-196. doi: 10.4274/ejbh.galenos.2021.2021-1-4. Erratum in: Eur J Breast Health. 2021 Jun 24;17(3):296. doi: 10.4274/ejbh.galenos.2021.2021-1-4.e001. PMID: 33870120; PMCID: PMC8025718.
9. Ostapenko V, Daugelavicius R, Jarmalaite S. Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line. Sci Rep. 2021 Mar 22;11(1):6556. doi: 10.1038/s41598-021-86120-6. PMID: 33753859; PMCID: PMC7985213.
10. Ostapenko V, Özbaş S, Özmen T, Özmen V, Pienkowski T, Sarria G, Selim A, Semiglazov V, Schneebaum S. The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future. Eur J Breast Health. 2022 Jul 1;18(3):205-221. doi: 10.4274/ejbh.galenos.2022.2022-4-3. PMID: 35855198; PMCID: PMC9255660.
11. Ostapenko V, Lelièvre L, Heil J, Knauer M, Weber WP. Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101). Breast Cancer Res Treat. 2023 Sep;201(2):215-225. doi: 10.1007/s10549-023-06999-9. Epub 2023 Jun 25. PMID: 37355526; PMCID: PMC10361860.
12. Ostapenko V, Weber WP, Matrai Z, Hayoz S, Tausch C, Henke G, Zimmermann F, Montagna G, Fitzal F, Gnant M, Ruhstaller T, Muenst S, Mueller A, Lelièvre L, Heil J, Knauer M, Egle D, Sávolt Á, Heidinger M, Kurzeder C; TAXIS Study Writing Group; Zwahlen DR, Gruber G, Ackerknecht M, Kuemmel S, Bjelic-Radisic V, Smanykó V, Vrieling C, Satler R, Hagen D, Becciolini C, Bucher S, Simonson C, Fehr PM, Gabriel N, Maráz R, Sarlos D, Dedes KJ, Leo C, Berclaz G, Fansa H, Hager C, Reisenberger K, Singer CF, Loibl S, Winkler J, Lam GT, Fehr MK, Kohlik M, Clerc K, Ostapenko V, Maggi N, Schulz A, Andreozzi M, Goldschmidt M, Saccilotto R, Markellou P. Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer. JAMA Surg. 2023 Oct 1;158(10):1013-1021. doi: 10.1001/jamasurg.2023.2840. PMID: 37466971; PMCID: PMC10357358.
13. Ostapenko E, Nixdorf L, Devyatko Y, Exner R, Wimmer K, Fitzal F. Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction: A Systemic Review and Meta-analysis. Ann Surg Oncol. 2023 Jan;30(1):126-136. doi: 10.1245/s10434-022-12567-0. Epub 2022 Oct 16. PMID: 36245049; PMCID: PMC9726796.
14. Ostapenko E, Montagna G, Mrdutt MM, Sun SX, Hlavin C, Diego EJ, Wong SM, Barrio AV, van den Bruele AB, Cabioglu N, Sevilimedu V, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Sträuli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Karanlik H, Dedes KJ, Romics L, Banys-Paluchowski M, Muslumanoglu M, Perez MDRC, Díaz MC, Heidinger M, Fehr MK, Reinisch M, Tukenmez M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Kuemmel S, Bruzas S, di Lascio S, Parissenti TK, Hoskin TL, Güth U, Ovalle V, Tausch C, Kuerer HM, Caudle AS, Boileau JF, Boughey JC, Kühn T, Morrow M, Weber WP. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncol. 2024 Jun 1;10(6):793-798. doi: 10.1001/jamaoncol.2024.0578. PMID: 38662396; PMCID: PMC11046400.
15. Ostapenko E, Nixdorf L, Devyatko Y, Exner R, Math P, Wimmer K, Haeusler T, Fitzal F. Ptotic versus Nonptotic Breasts in Nipple-sparing Mastectomy and Immediate Prepectoral Breast Reconstruction. Plast Reconstr Surg Glob Open. 2023 May 26;11(5):e5032. doi: 10.1097/GOX.0000000000005032. PMID: 37250830; PMCID: PMC10219702.
16. Ostapenko E, Nixdorf L, Devyatko Y, Exner R, Wimmer K, Fitzal F. The Impact of Adjuvant Radiotherapy on Immediate Prepectoral Implant-Based Breast Reconstruction. Aesthetic Plast Surg. 2024 Jul;48(13):2432-2438. doi: 10.1007/s00266-023-03661-z. Epub 2023 Sep 22. PMID: 37737875.
17. Ostapenko E, Lisa A, Carbonaro R, Bottoni M, Rietjens M. Bovine Acellular Dermal Matrix-Based Breast Reconstruction in Previously Irradiated Breasts: Complications and Outcomes From a Single-Center Experience. Ann Plast Surg. 2023 Dec 1;91(6):686-692. doi: 10.1097/SAP.0000000000003667. Epub 2023 Aug 19. PMID: 37624913.
18. Ostapenko E, Carbonaro R, Lisa A, Bottoni M, Rietjens M. Letter to the Editor regarding „Interest of acellular dermal matrices in immediate breast reconstruction: Comparison of quality of life and complications with and without matrix”. J Plast Reconstr Aesthet Surg. 2023 Dec;87:339-340. doi: 10.1016/j.bjps.2023.10.082. Epub 2023 Oct 18. PMID: 37925924.
19. Ostapenko E, Lisa AVE, Carbonaro R, Bottoni M, Colombo G, Gentilucci M, Vinci V, Nicosia L, De Lorenzi F, Rietjens M. Treatment of Capsular Contracture in Previously Irradiated Breasts Implants and Expanders with the Use of Porcine Acellular Dermal Matrices: Outcomes and Complications. J Clin Med. 2024 Sep 23;13(18):5653. doi: 10.3390/jcm13185653. PMID: 39337139; PMCID: PMC11433312.